Comparable Midterm Outcomes for Ultrasound‐Guided Needling Versus High‐Energy Shockwave Therapy for Rotator Cuff Calcific Tendinitis: A Randomized Controlled Trial
Arthroscopy · 2026-11 · 42 (11) · 2485-2493
DOI: 10.1002/arj.70405 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Arthroscopy, online erschienen am 24.07.2026. Verfasst von Dominic M van Noort und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Spaarne Gasthuis, Hoofddorp, Netherland. Hauptthemen laut MEDLINE: Tendinopathy, Calcinosis, Extracorporeal Shockwave Therapy, Rotator Cuff. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Purpose
To compare the midterm clinical and radiographic outcomes of extracorporeal shockwave therapy (ESWT) and ultrasound‐guided needling (UGN) in symptomatic calcific tendinitis of the rotator cuff (RCCT).
Methods
This study is a follow‐up of a randomized controlled trial. Eighty‐two patients with shoulder complaints due to RCCT (>5 mm in size, Gärtner type I‐II) persisting >4 months despite nonoperative treatment, including a subacromial corticosteroid injection, were allocated to ESWT (4 sessions of high‐energy ESWT) or UGN (single ultrasound‐guided puncture and lavage using two 17‐gauge needles). Outcomes at 5 years were the Constant‐Murley Score (CMS), Disabilities of the Arm, Shoulder, and Hand questionnaire, and visual analog scale for pain. Radiographs were used to evaluate the size, location, morphology, and recurrence of the deposits.
Results
The minimum follow‐up in this study was 5 years (mean 6.8 ± 1.1 years; range 60‐106 months). Sixty‐seven (82%) of the original 82 patients were included (43 females; 64%, mean age 51.8 ± 9.0 years). Baseline CMS was 67.4 ± 12.5. At 5 years, the mean CMS was 94.4 ± 6.4 and 93.3 ± 13.6 for ESWT and UGN, respectively ( P = .67). Ninety‐four percent of both groups achieved the minimal clinically important difference threshold value for CMS. Additional treatment was received by 42% and 26% of ESWT and UGN, respectively ( P = .17). No recurrence of calcific deposits was found in treated tendons. New deposits in a different rotator cuff tendon were observed in 15% of UGN patients.
Conclusions
Patients with RCCT treated with ESWT and UGN show excellent midterm clinical and radiographic outcomes, with most achieving clinically important difference threshold values without significant intergroup differences. Both treatment groups showed high rates of additional treatments with the potential of underpowered analysis. Level of Evidence Level II, randomized controlled trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Spaarne Gasthuis, Hoofddorp, Netherland.
- Department of Orthopaedic Surgery, Amphia Ziekenhuis, Breda, Netherlands.
- Department of Orthopaedic Surgery, Xpert Clinics, Amsterdam, Netherlands.
- Department Orthopedic Surgery and Sports Medicine, Amsterdam UMC, Amsterdam, Netherlands.
- Department of Orthopaedic Surgery, Erasmus MC, Rotterdam, Netherlands.
ORCID-Profile: Dominic M van Noort, Jan K G Louwerens, Inger N Sierevelt
Zitieren
APA
van Noort, D. M., Louwerens, J. K. G., Sierevelt, I. N., & van Noort, A. (2026). Comparable Midterm Outcomes for Ultrasound‐Guided Needling Versus High‐Energy Shockwave Therapy for Rotator Cuff Calcific Tendinitis: A Randomized Controlled Trial. Arthroscopy, 42(11), 2485-2493. https://doi.org/10.1002/arj.70405
Vancouver
van Noort DM, Louwerens JKG, Sierevelt IN, van Noort A. Comparable Midterm Outcomes for Ultrasound‐Guided Needling Versus High‐Energy Shockwave Therapy for Rotator Cuff Calcific Tendinitis: A Randomized Controlled Trial. Arthroscopy. 2026;42(11):2485-2493. doi:10.1002/arj.70405
BibTeX
@article{vanNoort2026,
author = {van Noort, Dominic M and Louwerens, Jan K G and Sierevelt, Inger N and van Noort, Arthur},
title = {Comparable Midterm Outcomes for Ultrasound‐Guided Needling Versus High‐Energy Shockwave Therapy for Rotator Cuff Calcific Tendinitis: A Randomized Controlled Trial},
journal = {Arthroscopy},
year = {2026},
volume = {42},
number = {11},
pages = {2485--2493},
doi = {10.1002/arj.70405}
}
EUVIMED